Statement Of Changes In Equity [Abstract]

Ascelia Pharma - Filing #701899

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through exercise of warrants, equity
- SEK
482,000 SEK
- SEK
3 853 SEK
3 371 SEK
3 853 SEK
- SEK
Increase (decrease) through transactions with owners, equity
SEK
5 879 SEK
SEK
197 546 SEK
185 100 SEK
197 546 SEK
6 567 SEK
3 818 SEK
5 208 SEK
97 696 SEK
SEK
SEK
97 696 SEK
88 670 SEK
Share issue related cost
- SEK
- SEK
- SEK
13 271 SEK
13 271 SEK
13 271 SEK
- SEK
- SEK
- SEK
5 286 SEK
- SEK
- SEK
5 286 SEK
5 286 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.